AR005999A1 - Nuevos derivados de eritromicina, su procedimiento de preparacion, composiciones farmaceuticas y medicamentos - Google Patents

Nuevos derivados de eritromicina, su procedimiento de preparacion, composiciones farmaceuticas y medicamentos

Info

Publication number
AR005999A1
AR005999A1 ARP970100760A ARP970100760A AR005999A1 AR 005999 A1 AR005999 A1 AR 005999A1 AR P970100760 A ARP970100760 A AR P970100760A AR P970100760 A ARP970100760 A AR P970100760A AR 005999 A1 AR005999 A1 AR 005999A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical compositions
preparation procedure
erythromycin
medicines
compounds
Prior art date
Application number
ARP970100760A
Other languages
English (en)
Spanish (es)
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of AR005999A1 publication Critical patent/AR005999A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
ARP970100760A 1996-02-28 1997-02-25 Nuevos derivados de eritromicina, su procedimiento de preparacion, composiciones farmaceuticas y medicamentos AR005999A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9602472A FR2745290B1 (fr) 1996-02-28 1996-02-28 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Publications (1)

Publication Number Publication Date
AR005999A1 true AR005999A1 (es) 1999-07-21

Family

ID=9489659

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970100760A AR005999A1 (es) 1996-02-28 1997-02-25 Nuevos derivados de eritromicina, su procedimiento de preparacion, composiciones farmaceuticas y medicamentos

Country Status (31)

Country Link
US (1) US6096714A (enExample)
EP (1) EP0885234B1 (enExample)
JP (1) JP4102440B2 (enExample)
KR (1) KR100486053B1 (enExample)
CN (1) CN1168734C (enExample)
AP (1) AP952A (enExample)
AR (1) AR005999A1 (enExample)
AT (1) ATE217633T1 (enExample)
AU (1) AU716204B2 (enExample)
BG (1) BG63207B1 (enExample)
BR (1) BR9707709B1 (enExample)
CZ (1) CZ293893B6 (enExample)
DE (1) DE69712610T2 (enExample)
DK (1) DK0885234T3 (enExample)
EA (1) EA001376B1 (enExample)
EE (1) EE9800265A (enExample)
ES (1) ES2176698T3 (enExample)
FR (1) FR2745290B1 (enExample)
HU (1) HU227567B1 (enExample)
IL (1) IL125622A (enExample)
NO (1) NO983955L (enExample)
NZ (1) NZ331600A (enExample)
OA (1) OA10845A (enExample)
PL (1) PL191736B1 (enExample)
PT (1) PT885234E (enExample)
SK (1) SK118498A3 (enExample)
TR (1) TR199801713T2 (enExample)
UA (1) UA58504C2 (enExample)
WO (1) WO1997031929A1 (enExample)
YU (1) YU37098A (enExample)
ZA (1) ZA971659B (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU9649698A (en) * 1997-10-29 1999-05-17 Taisho Pharmaceutical Co., Ltd. Erythromycin a 11, 12-carbamate derivatives
JP2003527301A (ja) * 1997-10-29 2003-09-16 大正製薬株式会社 エリスロマイシンａ誘導体
JP4573925B2 (ja) * 1998-07-09 2010-11-04 アベンティス・ファーマ・ソシエテ・アノニム 新規のエリスロマイシン誘導体、その製造方法及びその薬剤としての使用
FR2780977B1 (fr) * 1998-07-09 2000-09-01 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2792637B1 (fr) * 1999-04-26 2001-06-01 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2781484B1 (fr) * 1998-07-21 2001-08-10 Hoechst Marion Roussel Inc Nouveaux derives de la 6-deoxy erythromycine, leur procede de preparation et leur application comme medicaments
CZ20012675A3 (cs) 1999-01-27 2002-04-17 Pfizer Products Inc. Ketolidová antibiotika
BR0010938A (pt) * 1999-05-24 2002-03-19 Pfizer Prod Inc Derivados da 13-metil eritromicina
WO2001010879A1 (fr) * 1999-08-06 2001-02-15 Taisho Pharmaceutical Co., Ltd. Derives d'erythromycine a
WO2001010878A1 (fr) * 1999-08-06 2001-02-15 Taisho Pharmaceutical Co., Ltd. Derives d'erythromycine a
AU6183800A (en) * 1999-08-06 2001-03-05 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
EP1146051A3 (en) * 2000-04-10 2001-10-31 Pfizer Products Inc. Erythromycin A derivatives
US20020115621A1 (en) * 2000-08-07 2002-08-22 Wei-Gu Su Macrolide antibiotics
ITMI20021726A1 (it) * 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
US7601695B2 (en) 2003-03-10 2009-10-13 Optimer Pharmaceuticals, Inc. Antibacterial agents
US20050014706A1 (en) * 2003-07-14 2005-01-20 Kanakeshwari Falzari Method of treating tuberculosis
WO2007069264A2 (en) * 2005-12-15 2007-06-21 Alembic Limited Reference standards for determining the purity of telithromycin and processes therefor
EP2214484A4 (en) 2007-10-25 2013-01-02 Cempra Pharmaceuticals Inc PROCESS FOR PREPARING ANTIBACTERIAL MAKROLIDE AGENTS
CN102245195B (zh) * 2008-10-24 2016-01-13 森普拉制药公司 使用含三唑的大环内酯的生物防御
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
JP5914335B2 (ja) 2009-09-10 2016-05-11 センプラ ファーマシューティカルズ，インコーポレイテッド マラリア、結核、及びｍａｃ病の治療方法
EP3009442B1 (en) 2010-03-22 2019-06-19 Cempra Pharmaceuticals, Inc. Crystalline forms of a macrolide, and uses therefor
CA2799937A1 (en) 2010-05-20 2011-11-24 Cempra Pharmaceuticals, Inc. Processes for preparing macrolides and ketolides and intermediates therefor
WO2012034058A1 (en) 2010-09-10 2012-03-15 Cempra Pharmaceuticals, Inc. Hydrogen bond forming fluoro ketolides for treating diseases
CA2868262A1 (en) 2012-03-27 2013-10-03 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
HK1217665A1 (zh) 2013-03-14 2017-01-20 森普拉制药公司 用於治療呼吸道疾病的方法及其製劑
HK1218864A1 (zh) 2013-03-15 2017-03-17 森普拉制药公司 用於制备大环内酯抗菌剂的收敛方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US487411A (en) * 1892-12-06 Island
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of erythromycin derivatives
US5444031A (en) * 1993-01-21 1995-08-22 Calgon Carbon Corporation Process for making catalytic carbon
FR2727969B1 (fr) * 1994-12-09 1997-01-17 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
ZA971659B (en) 1998-02-26
YU37098A (sh) 1999-07-28
PT885234E (pt) 2002-10-31
ES2176698T3 (es) 2002-12-01
WO1997031929A1 (fr) 1997-09-04
DE69712610D1 (de) 2002-06-20
AU716204B2 (en) 2000-02-24
NO983955D0 (no) 1998-08-27
KR100486053B1 (ko) 2005-06-16
CN1168734C (zh) 2004-09-29
IL125622A0 (en) 1999-04-11
IL125622A (en) 2003-10-31
BG102691A (en) 1999-06-30
BG63207B1 (bg) 2001-06-29
TR199801713T2 (xx) 1998-12-21
HUP9902576A1 (hu) 1999-12-28
JP4102440B2 (ja) 2008-06-18
OA10845A (fr) 2003-02-05
US6096714A (en) 2000-08-01
ATE217633T1 (de) 2002-06-15
HU227567B1 (en) 2011-08-29
PL328608A1 (en) 1999-02-01
EA001376B1 (ru) 2001-02-26
DK0885234T3 (da) 2002-08-26
SK118498A3 (en) 1999-07-12
EP0885234B1 (fr) 2002-05-15
AU1929897A (en) 1997-09-16
PL191736B1 (pl) 2006-06-30
KR19990087324A (ko) 1999-12-27
JP2000505469A (ja) 2000-05-09
NZ331600A (en) 1999-08-30
FR2745290B1 (fr) 1998-04-03
AP9801318A0 (en) 1998-09-30
NO983955L (no) 1998-08-27
BR9707709A (pt) 1999-04-06
CN1212700A (zh) 1999-03-31
HUP9902576A3 (en) 2001-03-28
UA58504C2 (uk) 2003-08-15
CZ293893B6 (cs) 2004-08-18
DE69712610T2 (de) 2002-11-28
FR2745290A1 (fr) 1997-08-29
EA199800768A1 (ru) 1999-02-25
AP952A (en) 2001-03-29
EE9800265A (et) 1999-02-15
EP0885234A1 (fr) 1998-12-23
BR9707709B1 (pt) 2014-10-14
CZ258798A3 (cs) 1998-12-16

Similar Documents

Publication Publication Date Title
AR005999A1 (es) Nuevos derivados de eritromicina, su procedimiento de preparacion, composiciones farmaceuticas y medicamentos
CY1112274T1 (el) Νεοι ολιγοσακχαριτες, η παρασκευh τους και οι φαρμακευτικες συνθεσεις οι οποιες τους περιεχουν
AR001440A1 (es) Nuevos taxoides, su preparación y composiciones farmacéuticas que los contienen.
NO180538C (no) N-sulfonyl-2-oksoindol-derivater som har affinitet for vasopressin- og/eller ocytocin-reseptorer, farmasöytiske blandinger som inneholder dem og mellomprodukter ved fremstilling av derivatene
CO4940450A1 (es) Formulaciones farmaceuticas que contienen voriconazol
ATE218581T1 (de) Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung
DK0578083T3 (da) Cykliske adhæsionsinhibitorer
ES2095432T3 (es) Derivados de 2,4-tiazolidin-diona, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
HUP0001232A2 (hu) Béta-amiloid peptid kibocsátást és/vagy szintézist gátló cikloalkil-, laktám-, laktonszármazékok, és ezek tio-analógjai, valamint e vegyületeket tartalmazó gyógyászati készítmények
FI943749A0 (fi) Taksaanijohdannaisten fosfono-oksimetyylieetterit
NO20006323D0 (no) Glykopeptidderivater og farmasöytiske sammensetninger som inneholder disse
NO304884B1 (no) 9-[(substituerte glycyl)amido]-6-demetyl-6-deoksotetracykliner, og medisinske preparater derav
DE69424517D1 (de) Gaserzeugende Zusammensetzungen
GR3000287T3 (en) Taxol derivatives, their preparation and pharmaceutical compositions containing them
NO971889L (no) Forbindelser og sammensetninger for levering av aktive midler
CO4700531A1 (es) Compuestos y composiciones que comprenden un derivado de fosfato y un vehiculo que proveen una sensacion de calenta- miento
MX9207394A (es) Esteroides de 17-espirofuran-3'-ilideno.
HUP0103203A2 (hu) Azaadamantánszármazékok és ezeket tartalmazó gyógyszerkészítmények
DK0736029T3 (da) Antikonvulsive pseudofructopyranosesulfamater
FI913556A0 (fi) Nya piperidyletrar och -tioetrar som inhibitorer av kolesterolbiosyntes.
UA48958C2 (uk) 9-o-оксимові похідні еритроміцину а та фармацевтична композиція на їх основі
DK0564358T3 (da) 3-aminochroman-spiro-derivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende sådanne
ES2119874T3 (es) Nuevos derivados de elipticina, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
DE69613395D1 (de) Schwefelenthaltende di-ter-butylphenol-verbindungen brauchbar als entzündungshemmende mittel
ES2162986T3 (es) Derivados de mercapto-alcanoil-dipeptidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.